812 Urelumab (anti-CD137 agonist) in combination with vaccine and nivolumab treatments is safe and associated with pathologic response as neoadjuvant and adjuvant therapy for resectable pancreatic cancer

812 Urelumab (anti-CD137 agonist) in combination with vaccine and nivolumab treatments is safe and associated with pathologic response as neoadjuvant and adjuvant therapy for resectable pancreatic cancer

Bibliographic Details
Main Authors:	Hao Wang, Elizabeth Thompson, Lei Zheng, Dung Le, Christopher Wolfgang, Robert Anders, Jin He, Carol Judkins, Jessica Hoare, Rachel Klein, Rose Parkinson, Haihui Cao, Jennifer Durham, Katrina Purtell, Ana De Jesus-Acosta, Amol Narang, Richard Burkhart, William Burns, Daniel Laheru
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

647 Evaluation of efficacy and toxicity of CD137 immunotherapy with urelumab-mIgG1 chimeric antibody in CD137 HuGEMM™
by: Daniel He, et al.
Published: (2020-11-01)

Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
by: S. Michael Chin, et al.
Published: (2018-11-01)

Daratumumab in combination with urelumab to potentiate anti-myeloma activity in lymphocyte-deficient mice reconstituted with human NK cells
by: Maria C. Ochoa, et al.
Published: (2019-07-01)

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
by: David Jones, et al.
Published: (2020-07-01)

Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumab
by: Jianwei Zhang, et al.
Published: (2019-12-01)

A commentary on Ovid's Ars Amatoria, III, 499-812
by: Gibson, Roy K.
Published: (1993)

J. S. Bach French Suites for keyboard, BWV 812-817
by: Chia-Yeh Lu, et al.
Published: (2004)

Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01)

Obtaining fermented dairy products with the yogurt culture YF-L 812
by: INA VASILEAN, et al.
Published: (2011-07-01)

Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
by: Sailaja Battula, et al.
Published: (2021-01-01)

PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma
by: David J. Pinato, et al.
Published: (2021-03-01)

Disaster Recovery of the 812 Tianjin Port Explosion : Industrial Space Change and Planning
by: JIANG, CHEN-JI, et al.
Published: (2018)

A case of locally advanced gastric cancer treated with nivolumab, trastuzumab, plus chemotherapy in a neoadjuvant setting
by: Shi-Yu Jiang, et al.
Published: (2019-06-01)

Analysis of Ocular Injury Characteristics in Survivors of the 8.12 Tianjin Port Explosion, China
by: Hao Jiang, et al.
Published: (2019-01-01)

Modulation of NK Cell Function with Agonistic α-CD137 Antibodies During MCMV Infection
by: Hahm, Dahn
Published: (2017)

P8.12 CAROTID ARTERY WAVE INTENSITY ANALYSIS IN HEALTHY HUMANS DURING EXERCISE
by: Nicola Pomella*, et al.
Published: (2015-11-01)

http://revista.ismm.edu.cu/index.php/revistamg/article/view/812/Uboho
by: Eduardo Manuel Díaz-Cedré, et al.
Published: (2013-12-01)

Mold design, fabrication and tensile testing of EMBed-812, a tissue embedding epoxy resin
by: Du, Lucy W
Published: (2015)

Abstract OR-6: Baseplate Structure of Bacteriophage Phi812 and Mechanism of Cell Wall Binding and Penetration
by: Ján Bíňovský, et al.
Published: (2021-06-01)

An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses
by: Jun P. Hong, et al.
Published: (2020-06-01)

814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
by: Mark Throsby, et al.
Published: (2020-11-01)

377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects
by: Nicholas Wilson, et al.
Published: (2020-11-01)

Timing to surgery of Chiari malformation type 1 affects complication types: An analysis of 13,812 patients
by: Sara Naessig, et al.
Published: (2020-01-01)

P8.12 ASSOCIATION BETWEEN ASYMMETRIC DIMETHYLARGININE AND THE INDICES OF VASCULAR FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: M. Sergejev, et al.
Published: (2009-12-01)

P8.12 ARTERIAL DISTENSION-PRESSURE LOOP ANALYSIS IN HYPERTENSIVE RATS: ADVANTAGES, PITFALLS AND POSSIBILITIES
by: C. Vayssettes-Courchay, et al.
Published: (2014-11-01)

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries
by: Alhabib, K.F, et al.
Published: (2020)

Association of dairy consumption with metabolic syndrome, hypertension and diabetes in 147 812 individuals from 21 countries
by: Khalid Yusoff, et al.
Published: (2020-04-01)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
by: Bin Li, et al.
Published: (2021-06-01)

Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
by: Dante J. Merlino, et al.
Published: (2020-12-01)

Славянский перевод апокрифа "Didascalia Domini / Откровение святым апостолaм" (BHG 812a-e)
by: Йоханнес Райнхарт
Published: (2014-08-01)

Correction: Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Published: (2021-08-01)

FOCUS ON NIVOLUMAB IN NSCLC
by: Diego Luigi Cortinovis, et al.
Published: (2016-12-01)

Identifying immune-related biomarkers to predict clinical outcomes of neoadjuvant immuno-chemotherapy (nivolumab, gemcitabine and cisplatin) in muscle-invasive bladder cancer (NCT03294304)
by: M. Eckstein, et al.
Published: (2020-07-01)

P8.12 GENETIC INFLUENCES ON THE RELATION BETWEEN EXHALED NITRIC OXIDE AND ARTERIAL STIFFNESS: A TWIN STUDY
by: D.L. Tarnoki, et al.
Published: (2011-11-01)

A Study of J. S. Bach′s French Suites for Keyboard, BWV812-817:The Examples of Allemande、Courante、Sarabande and Gigue.
by: Hui-fang Wu, et al.
Published: (2005)

Nivolumab-Induced Thyroid Dysfunction
by: Lohit Kumbar, et al.
Published: (2021-01-01)

Nivolumab and immune‐mediated colitis
by: Heather Walker, et al.
Published: (2019-04-01)

Antiphospholipid Antibody Induced by Nivolumab
by: Ahmed Aburahma, et al.
Published: (2018-01-01)

303 Phase II trial of neoadjuvant nivolumab (Nivo) and intra-tumoral (IT) CMP-001 in high-risk resectable melanoma (Neo-C-Nivo): final results
by: Hassane Zarour, et al.
Published: (2020-11-01)

Transition of the PD-1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re-challenge
by: Funakoshi, Y., et al.
Published: (2022)